which has fewer side effects semaglutide or tirzepatide Comparative safety and of and tirzepatide: Implications for clinical decision-making in obesity management Compare GLP-1 Options | Ozempic

Consider centrally acting agents like PT-141 in select cases resistant to peripheral pathways

This is particularly helpful for those who lead active lifestyles and want to support their recovery after exercise

In patients with obesity and type 2 diabetes, carnitine supplementation improves insulin-induced glucose utilization and increases fatty acid oxidation rates

- Simpler adherence one inhaler, twice a day, no nebulizer or capsules

Register ADVERTISEMENT ADVERTISEMENT GLP-1 agonists can help patients with obesity achieve significant weight loss and associated health benefits We need to see obesity predominantly as a disease state, which has evolved in the context of an obesogenic environment

Our clinic also educates patients on why availability drives long-term success